Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.

Saved in:
Bibliographic Details
Title: Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
Authors: Webb MJ; Department of Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Neth BJ; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Webb LM; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA., Van Gompel JJ; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Link MJ; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Neff BA; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Carlson ML; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Driscoll CL; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Dornhoffer J; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA., Ruff MW; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Anderson KA; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA., Kizilbash SH; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Campian JL; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Uhm JH; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Lane JI; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Benson JC; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Blezek DJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Mehta PM; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Bathla G; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Sener UT; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2023 Sep 22; Vol. 5 (1), pp. vdad123. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37841698
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Webb+MJ%22">Webb MJ</searchLink>; Department of Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Neth+BJ%22">Neth BJ</searchLink>; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Webb+LM%22">Webb LM</searchLink>; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Van+Gompel+JJ%22">Van Gompel JJ</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Link+MJ%22">Link MJ</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Neff+BA%22">Neff BA</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Carlson+ML%22">Carlson ML</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Driscoll+CL%22">Driscoll CL</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Dornhoffer+J%22">Dornhoffer J</searchLink>; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Ruff+MW%22">Ruff MW</searchLink>; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+KA%22">Anderson KA</searchLink>; Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Kizilbash+SH%22">Kizilbash SH</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Campian+JL%22">Campian JL</searchLink>; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Uhm+JH%22">Uhm JH</searchLink>; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Lane+JI%22">Lane JI</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Benson+JC%22">Benson JC</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Blezek+DJ%22">Blezek DJ</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Mehta+PM%22">Mehta PM</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Bathla+G%22">Bathla G</searchLink>; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Sener+UT%22">Sener UT</searchLink>; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2023 Sep 22; Vol. 5 (1), pp. vdad123. <i>Date of Electronic Publication: </i>2023 Sep 22 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37841698
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdad123
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdad123
    Titles:
      – TitleFull: Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Webb MJ
      – PersonEntity:
          Name:
            NameFull: Neth BJ
      – PersonEntity:
          Name:
            NameFull: Webb LM
      – PersonEntity:
          Name:
            NameFull: Van Gompel JJ
      – PersonEntity:
          Name:
            NameFull: Link MJ
      – PersonEntity:
          Name:
            NameFull: Neff BA
      – PersonEntity:
          Name:
            NameFull: Carlson ML
      – PersonEntity:
          Name:
            NameFull: Driscoll CL
      – PersonEntity:
          Name:
            NameFull: Dornhoffer J
      – PersonEntity:
          Name:
            NameFull: Ruff MW
      – PersonEntity:
          Name:
            NameFull: Anderson KA
      – PersonEntity:
          Name:
            NameFull: Kizilbash SH
      – PersonEntity:
          Name:
            NameFull: Campian JL
      – PersonEntity:
          Name:
            NameFull: Uhm JH
      – PersonEntity:
          Name:
            NameFull: Lane JI
      – PersonEntity:
          Name:
            NameFull: Benson JC
      – PersonEntity:
          Name:
            NameFull: Blezek DJ
      – PersonEntity:
          Name:
            NameFull: Mehta PM
      – PersonEntity:
          Name:
            NameFull: Bathla G
      – PersonEntity:
          Name:
            NameFull: Sener UT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 09
              Text: 2023 Sep 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1